Share This Page
Bulk Pharmaceutical API Sources for BLEPHAMIDE S.O.P.
✉ Email this page to a colleague
Bulk Pharmaceutical API Sources for BLEPHAMIDE S.O.P.
| Vendor | Vendor Homepage | Vendor Sku | API Url |
|---|---|---|---|
| Sigma-Aldrich | ⤷ Start Trial | P8650_SIGMA | ⤷ Start Trial |
| TCI (Tokyo Chemical Industry) | ⤷ Start Trial | P1283 | ⤷ Start Trial |
| MolPort | ⤷ Start Trial | MolPort-002-507-143 | ⤷ Start Trial |
| Hangzhou APIChem Technology | ⤷ Start Trial | AC-2176 | ⤷ Start Trial |
| >Vendor | >Vendor Homepage | >Vendor Sku | >API Url |
Bulk Active Pharmaceutical Ingredient (API) Sources for Blephamide S.O.P.
What are the primary API sources for Blephamide S.O.P.?
Blephamide contains two active ingredients: sulfamethoxazole and dexamethasone. These are produced by various manufacturing entities worldwide, adhering to regulatory standards set by agencies such as the FDA (United States), EMA (European Union), and other global regulators.
Sourcing of Sulfamethoxazole
Leading API Manufacturers
| Manufacturer | Location | Certification | Remarks |
|---|---|---|---|
| Hubei Hhubei Pharmaceutical Co. Ltd. | China | GMP, DMF | Large-scale producer, supplies global markets |
| Zhejiang Xianju Pharmaceutical Co. | China | GMP | Known for high purity sulfamethoxazole |
| Synthelabo (Sanofi) | France | DMF, cGMP | Established pharmaceuticals, global reach |
| Jianfeng Pharmaceutical Co. Ltd. | China | GMP | Supplier for sterile and non-sterile APIs |
| Wockhardt Ltd. | India | GMP | Focused on quality APIs, significant export volume |
Key Considerations
- Regulatory approvals: Choose suppliers with DMF filings and GMP certifications.
- Supply stability: Prefer manufacturers with global distribution and consistent production capacity.
- Quality assurance: Certifications such as ISO 9001, ISO 13485, and batch testing reports.
Sourcing of Dexamethasone
Leading API Manufacturers
| Manufacturer | Location | Certification | Remarks |
|---|---|---|---|
| Precise Pharmaceuticals | India | GMP, DMF | Focus on synthetic corticosteroids |
| Zhejiang Xianju Pharmaceutical Co. | China | GMP | Dominant in Asian markets |
| Sigma-Aldrich (Merck) | United States/Europe | cGMP, DMF | Known for high-quality APIs |
| Sandoz (Novartis) | Switzerland | DMF, cGMP | Established global supplier |
Key Considerations
- API specifications: Dexamethasone APIs must meet BP, USP, or EP standards.
- Batch consistency: Manual and automated testing for potency, impurities, and residual solvents.
Global Regulatory Landscape
- United States (FDA): API manufacturers must have a Drug Master File (DMF) for validation and data integrity.
- European Union (EMA): EMA-approved APIs must comply with the European Pharmacopoeia (Ph. Eur.).
- Other regions: Indian and Chinese suppliers frequently supply to global markets, with specific inspection and certification requirements.
Market Trends and Supply Chain Dynamics
- Growing demand: Increasing use of Blephamide for ophthalmic infections drives higher API procurement volumes.
- Supply chain shifts: Pandemic disruptions caused supply bottlenecks; companies seek diversified sources.
- Quality standards: Industry trend towards suppliers meeting stricter quality controls and environmental standards like ISO 14001.
Summary of Leading API Suppliers
| Ingredient | Primary Regions | Certification Standards | Typical Certification & Documentation |
|---|---|---|---|
| Sulfamethoxazole | China, France, India | GMP, DMF | Batch testing reports, stability data, purity assays |
| Dexamethasone | India, China, Switzerland | GMP, DMF, cGMP | Certificate of Analysis, regulatory filings |
Key Takeaways
- Major sulfamethoxazole and dexamethasone API sources are based in China, India, Europe, and the US.
- Certifications such as GMP and DMF are critical for regulatory compliance.
- Diversified sourcing minimizes supply chain disruptions and ensures quality.
- Consistent evaluation of batch testing and supplier audits remains necessary.
FAQs
1. How are API quality standards verified?
Quality is confirmed through batch testing, documentation like Certificates of Analysis (COA), compliance with pharmacopeia standards (BP, USP, EP), and regulatory audits.
2. Which regions dominate API production for Blephamide?
China and India are the primary regions, with European and US suppliers providing high-quality APIs with extensive regulatory validation.
3. What are common certification requirements for suppliers?
Suppliers should possess GMP certification, DMF filings, and ISO certifications. These ensure adherence to quality, safety, and regulatory standards.
4. How do supply chain disruptions impact API sourcing?
Global events, such as the COVID-19 pandemic, have caused shortages and delays. Companies adopt diversified sourcing and stockpiling to mitigate risks.
5. Are there any recent regulatory alerts concerning API suppliers?
Regulatory agencies periodically issue warning notices for non-compliance; ongoing supplier validation and audit procedures help ensure regulatory adherence.
References
[1] U.S. Food and Drug Administration. (2022). Drug Master Files (DMFs). https://www.fda.gov/drugs/drug-approvals-and-databases/drug-master-files
[2] European Medicines Agency. (2022). Pharmacovigilance and API regulations. https://www.ema.europa.eu/en/human-regulatory/overview/pharmacovigilance
[3] WHO Expert Committee on Specifications for Pharmaceutical Preparations. (2021). Guidelines on Good Manufacturing Practices. World Health Organization.
[4] Global Industry Analysts. (2022). API Market Outlook for 2023 and Beyond.
[5] Pharmaceutical Technology. (2021). API sourcing trends and supplier assessments.
More… ↓
